Impedimed device gets breakthrough designation for kidney failure
The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis.
The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis.
The company's first product, a diagnostic aid known as KidneyIntelX is aiming to identify patients at risk for particularly fast progression of kidney disease.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.